Cell Source, Inc.
CLCS · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $14,655 | $14,359 | $29,611 | $35,988 |
| - Cash | $75 | $22 | $223 | $93 |
| + Debt | $10,068 | $9,254 | $7,904 | $6,469 |
| Enterprise Value | $24,648 | $23,591 | $37,292 | $42,365 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$3,603 | -$4,220 | $0 | -$93 |
| % Margin | – | – | – | – |
| Net Income | -$4,771 | -$5,321 | -$5,168 | -$5,472 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.15 | -0.17 | -0.18 | -0.19 |
| % Growth | 11.8% | 5.6% | 5.3% | – |
| Operating Cash Flow | -$2,684 | -$2,348 | -$3,139 | -$3,379 |
| Capital Expenditures | $0 | $0 | -$0 | $0 |
| Free Cash Flow | -$2,684 | -$2,348 | -$3,139 | -$3,379 |